Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT05479578 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05479578
Sponsor: Rashmi Verma, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Metastatic Prostate Adenocarcinoma Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) V8

Start date: 2022-06-29
Primary completion: 2025-05-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.